ELCYS is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Exela Pharma Sciences, Llc. The primary component is Cysteine Hydrochloride.
| Product ID | 51754-1007_3f3dc2d1-9383-4c95-b97a-3e25c588d8a4 |
| NDC | 51754-1007 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ELCYS |
| Generic Name | Cysteine Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-05-28 |
| Marketing Category | NDA / NDA |
| Application Number | NDA210660 |
| Labeler Name | Exela Pharma Sciences, LLC |
| Substance Name | CYSTEINE HYDROCHLORIDE |
| Active Ingredient Strength | 10 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-05-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA210660 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-28 |
| Marketing Category | NDA |
| Application Number | NDA210660 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-05-28 |
| Ingredient | Strength |
|---|---|
| CYSTEINE HYDROCHLORIDE | 10 mg/mL |
| SPL SET ID: | e7652275-1c53-490c-82ad-e63867df5788 |
| Manufacturer | |
| UNII |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51754-1007 | ELCYS | Cysteine Hydrochloride |
| 0338-9645 | CYSTEINE HYDROCHLORIDE | cysteine hydrochloride |
| 76014-006 | Nouress | cysteine hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ELCYS 88350906 5899186 Live/Registered |
Exela Holdings, Inc. 2019-03-21 |